Skip to main content
Total Market Cap: $93,365,888,912 Volume (24h): $4,809,978,213

InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. (IN) logo
Rank 19
About

Specialising in cannabinoid-based therapies, InMed Pharmaceuticals is a biopharmaceutical company that focuses on conditions resistant to traditional practices. The company is also developing a biosynthesis process so it can replicate cannabinoids without the need to grow cannabis plants. Based in Vancouver, Canada, they have access to an extensive database of cannabinoid drug information.

Website
$4.2145
USD
-2.36%
Market cap
$726,095,763
Total volume
$147,613
Shares outstanding
172,283,633
Rank 19
Website
About

Specialising in cannabinoid-based therapies, InMed Pharmaceuticals is a biopharmaceutical company that focuses on conditions resistant to traditional practices. The company is also developing a biosynthesis process so it can replicate cannabinoids without the need to grow cannabis plants. Based in Vancouver, Canada, they have access to an extensive database of cannabinoid drug information.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
TSX
IN
$107,479
72.81%
$4.2145
OTC
IMLFF
Total volume
$40,134
27.19%
Stock price
$0.1900
Chart
Social media
Tweets by @inmedpharma
InMed Pharmaceuticals Inc.

Share widget

Copy widget code
Subscribe to our newsletter